Literature DB >> 12719577

Mutations proximal to the minor groove-binding track of human immunodeficiency virus type 1 reverse transcriptase differentially affect utilization of RNA versus DNA as template.

Timothy S Fisher1, Tom Darden, Vinayaka R Prasad.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT), like all retroviral RTs, is a versatile DNA polymerase that can copy both RNA and DNA templates. In spite of extensive investigations into the structure-function of this enzyme, the structural basis for this dual template specificity is poorly understood. Biochemical studies with two mutations in HIV-1 RT that affect residues contacting the template-primer now provide some insight into this specialized property. The mutations are N255D and N265D, both adjoining the minor groove-binding track, in the thumb region. The N265D substitution led to a loss of processive polymerization on DNA but not on RNA, whereas N255D drastically reduced processive synthesis on both templates. This differential template usage was accompanied by a rapid dissociation of the N265D variant on DNA but not RNA templates, whereas the N255D variant rapidly dissociated from both templates. Molecular dynamics modeling suggested that N265D leads to a loss of template strand-specific hydrogen bonding, indicating that this is a key determinant of the differential template affinity. The N255D substitution caused local changes in conformation and a consequent loss of interaction with the primer, leading to a loss of processive synthesis with both templates. We conclude that N265 is part of a subset of template-enzyme contacts that enable RT to utilize DNA templates in addition to RNA templates and that such residues play an important role in facilitating processive DNA synthesis on both RNA and DNA templates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719577      PMCID: PMC154037          DOI: 10.1128/jvi.77.10.5837-5845.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Phylogenetic analyses of 55 retroelements on the basis of the nucleotide and product amino acid sequences of the pol gene.

Authors:  M D Li; D L Bronson; T D Lemke; A J Faras
Journal:  Mol Biol Evol       Date:  1995-07       Impact factor: 16.240

2.  High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus.

Authors:  D J Schneider; J Feigon; Z Hostomsky; L Gold
Journal:  Biochemistry       Date:  1995-07-25       Impact factor: 3.162

3.  The K65R mutation confers increased DNA polymerase processivity to HIV-1 reverse transcriptase.

Authors:  D Arion; G Borkow; Z Gu; M A Wainberg; M A Parniak
Journal:  J Biol Chem       Date:  1996-08-16       Impact factor: 5.157

4.  Conferring RNA polymerase activity to a DNA polymerase: a single residue in reverse transcriptase controls substrate selection.

Authors:  G Gao; M Orlova; M M Georgiadis; W A Hendrickson; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

5.  Increased polymerase fidelity of E89G, a nucleoside analog-resistant variant of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  W C Drosopoulos; V R Prasad
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  Alterations to the primer grip of p66 HIV-1 reverse transcriptase and their consequences for template-primer utilization.

Authors:  M Ghosh; P S Jacques; D W Rodgers; M Ottman; J L Darlix; S F Le Grice
Journal:  Biochemistry       Date:  1996-07-02       Impact factor: 3.162

7.  Sensitivity of wild-type human immunodeficiency virus type 1 reverse transcriptase to dideoxynucleotides depends on template length; the sensitivity of drug-resistant mutants does not.

Authors:  P L Boyer; C Tantillo; A Jacobo-Molina; R G Nanni; J Ding; E Arnold; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  Glutamine 151 participates in the substrate dNTP binding function of HIV-1 reverse transcriptase.

Authors:  S G Sarafianos; V N Pandey; N Kaushik; M J Modak
Journal:  Biochemistry       Date:  1995-05-30       Impact factor: 3.162

9.  Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase.

Authors:  M A Wainberg; W C Drosopoulos; H Salomon; M Hsu; G Borkow; M Parniak; Z Gu; Q Song; J Manne; S Islam; G Castriota; V R Prasad
Journal:  Science       Date:  1996-03-01       Impact factor: 47.728

10.  Mutating the "primer grip" of p66 HIV-1 reverse transcriptase implicates tryptophan-229 in template-primer utilization.

Authors:  P S Jacques; B M Wöhrl; M Ottmann; J L Darlix; S F Le Grice
Journal:  J Biol Chem       Date:  1994-10-21       Impact factor: 5.157

View more
  9 in total

1.  High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations.

Authors:  Francesca Ceccherini-Silberstein; Federico Gago; Maria Santoro; Caterina Gori; Valentina Svicher; Fátima Rodríguez-Barrios; Roberta d'Arrigo; Massimo Ciccozzi; Ada Bertoli; Antonella d'Arminio Monforte; Jan Balzarini; Andrea Antinori; Carlo-Federico Perno
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 2.  Molecular dynamics simulations of RNA: an in silico single molecule approach.

Authors:  S Elizabeth McDowell; Nad'a Spacková; Jirí Sponer; Nils G Walter
Journal:  Biopolymers       Date:  2007-02-05       Impact factor: 2.505

3.  Duplex structural differences and not 2'-hydroxyls explain the more stable binding of HIV-reverse transcriptase to RNA-DNA versus DNA-DNA.

Authors:  Jeffrey T Olimpo; Jeffrey J DeStefano
Journal:  Nucleic Acids Res       Date:  2010-03-24       Impact factor: 16.971

4.  Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA.

Authors:  Anna-Maria Herzner; Cristina Amparo Hagmann; Marion Goldeck; Steven Wolter; Kirsten Kübler; Sabine Wittmann; Thomas Gramberg; Liudmila Andreeva; Karl-Peter Hopfner; Christina Mertens; Thomas Zillinger; Tengchuan Jin; Tsan Sam Xiao; Eva Bartok; Christoph Coch; Damian Ackermann; Veit Hornung; Janos Ludwig; Winfried Barchet; Gunther Hartmann; Martin Schlee
Journal:  Nat Immunol       Date:  2015-09-07       Impact factor: 25.606

5.  PCR inhibition by reverse transcriptase leads to an overestimation of amplification efficiency.

Authors:  Oleg Suslov; Dennis A Steindler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

6.  HIV-1 reverse transcriptase mutations that confer decreased in vitro susceptibility to anti-RT DNA aptamer RT1t49 confer cross resistance to other anti-RT aptamers but not to standard RT inhibitors.

Authors:  Timothy S Fisher; Pheroze Joshi; Vinayaka R Prasad
Journal:  AIDS Res Ther       Date:  2005-10-05       Impact factor: 2.250

7.  Modelling evolution on design-by-contract predicts an origin of life through an abiotic double-stranded RNA world.

Authors:  Albert D G de Roos
Journal:  Biol Direct       Date:  2007-04-27       Impact factor: 4.540

8.  Detection limits of several commercial reverse transcriptase enzymes: impact on the low- and high-abundance transcript levels assessed by quantitative RT-PCR.

Authors:  Jean-Philippe Levesque-Sergerie; Mathieu Duquette; Catherine Thibault; Louis Delbecchi; Nathalie Bissonnette
Journal:  BMC Mol Biol       Date:  2007-10-22       Impact factor: 2.946

9.  Active site binding and sequence requirements for inhibition of HIV-1 reverse transcriptase by the RT1 family of single-stranded DNA aptamers.

Authors:  Jay D Kissel; Daniel M Held; Richard W Hardy; Donald H Burke
Journal:  Nucleic Acids Res       Date:  2007-07-21       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.